Gilead shares rise 5% on report of AstraZeneca's interest in megamerger

Shares of U.S. drugmaker Gilead Sciences Inc rose over 5% in premarket trading on Monday after a report it had been approached by Britain's AstraZeneca for a possible merger to form one of the world's largest drug companies.